These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37227313)
1. Direct oral anticoagulant drugs for the management of venous thromboembolism. Thanavaro JL Nurse Pract; 2023 Jun; 48(6):27-35. PubMed ID: 37227313 [TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis. Dawwas GK; Dietrich E; Smith SM; Davis K; Park H Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of direct oral anticoagulants over warfarin in Japanese patients with acute venous thromboembolism: A meta-analysis. Senoo K; Kondo Y; Miyazawa K; Isogai T; Chun YH; Kobayashi Y J Cardiol; 2017 May; 69(5):763-768. PubMed ID: 27502316 [TBL] [Abstract][Full Text] [Related]
4. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism. Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657 [TBL] [Abstract][Full Text] [Related]
6. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention. Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466 [TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism. Fang MC; Reynolds K; Fan D; Prasad PA; Sung SH; Portugal C; Garcia E; Go AS JAMA Netw Open; 2023 Aug; 6(8):e2328033. PubMed ID: 37581888 [TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism. Comerota AJ; Ramacciotti E Am J Med Sci; 2016 Jul; 352(1):92-106. PubMed ID: 27432042 [TBL] [Abstract][Full Text] [Related]
9. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism. Roetker NS; Lutsey PL; Zakai NA; Alonso A; Adam TJ; MacLehose RF Thromb Haemost; 2018 Sep; 118(9):1637-1645. PubMed ID: 30103250 [TBL] [Abstract][Full Text] [Related]
10. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis. Boonyawat K; Caron F; Li A; Chai-Adisaksopha C; Lim W; Iorio A; Lopes RD; Garcia D; Crowther MA J Thromb Haemost; 2017 Jul; 15(7):1322-1333. PubMed ID: 28407368 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism. Fang MC; Go AS; Prasad PA; Hsu JW; Fan D; Portugal C; Sung SH; Reynolds K J Thromb Thrombolysis; 2021 Nov; 52(4):1101-1109. PubMed ID: 33834371 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants]. Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024 [TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism. Kang HR; Dietrich EA; Huang PL; Lo-Ciganic WH; DeRemer CE; Park H Clin Transl Sci; 2023 Jun; 16(6):946-954. PubMed ID: 36891985 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Rollins BM; Silva MA; Donovan JL; Kanaan AO Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394 [TBL] [Abstract][Full Text] [Related]
15. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study. Badreldin H J Thromb Thrombolysis; 2018 Jul; 46(1):16-21. PubMed ID: 29626281 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis. Elshafei MN; Mohamed MFH; El-Bardissy A; Ahmed MB; Abdallah I; Elewa H; Danjuma M J Thromb Thrombolysis; 2021 Feb; 51(2):388-396. PubMed ID: 32556939 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis. Chen HY; Ou SH; Huang CW; Lee PT; Chou KJ; Lin PC; Su YC Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339 [TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight. Perales IJ; San Agustin K; DeAngelo J; Campbell AM Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028 [No Abstract] [Full Text] [Related]
19. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism. Robertson L; Yeoh SE; Ramli A Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism. Coons JC; Albert L; Bejjani A; Iasella CJ Pharmacotherapy; 2020 Mar; 40(3):204-210. PubMed ID: 31968126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]